ROTH Capital downgraded Soliton from Buy to Neutral

Cantor Fitzgerald downgraded Soliton from Overweight to Neutral and set a new price target of $22.60 from $25.00 previously

Cantor Fitzgerald downgraded Soliton from Overweight to Neutral

Maxim Group resumed coverage of Soliton with a rating of Buy and set a new price target of $25.00

Maxim Group reiterated coverage of Soliton with a rating of Buy and set a new price target of $25.00 from $22.00 previously

Cantor Fitzgerald reiterated coverage of Soliton with a rating of Overweight and set a new price target of $20.00 from $12.00 previously

IRVINE, Calif., Dec. 16, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE:ABBV), today announced the successful completion of its acquisition of Soliton, Inc. (NASDAQ:SOLY). The addition of Soliton and its technology complements Allergan Aesthetics' portfolio of non-invasive body contouring treatments to now include a proven treatment for the appearance of cellulite. The RESONIC™ device initially received U.S. Food and Drug Administration (FDA) 510(k) clearance for the short-term improvement in the appearance of cellulite, and that clearance has now been expanded to long-term improvement up to one year. In recent clinical data submitted to the FDA, RESONIC™ demonstrated sig

NEW YORK, NY / ACCESSWIRE / May 13, 2021 / Soliton, Inc. /Tx/ (NASDAQ:SOLY) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 13, 2021 at 4:30 PM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/event/presentation/78926To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile.About Investor NetworkInvestor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what's trending. Dedicated to both the profess

HOUSTON, Feb. 10, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced Brad Hauser, President & CEO of Soliton, has been named as an Aesthetic Industry Association (AIA) advisory board member. "I am excited to be joining the Aesthetic Industry Association advisory board as I believe this association provides substantial thought leadership to the aesthetic industry," commented Brad Hauser, President & CEO of Soliton. "As Soliton continues to elevate the market and drive towards commercialization, the learnings will create a real symbiotic relationship between Sol

HOUSTON, Feb. 1, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced that the U.S. Food and Drug Administration ("FDA") has cleared its Rapid Acoustic Pulse ("RAP") technology for the short-term improvement in the appearance of cellulite. This innovative technology harnesses the power of sound for the treatment of cellulite. The unique, rapid-pulsed technology safely and comfortably breaks apart the fibrous septa bands beneath the skin that cause cellulite to deliver efficacious results in just one, 40–60-minute treatment. "We're thrilled to receive this lates

4 - Soliton, Inc. (0001548187) (Issuer)

4 - Soliton, Inc. (0001548187) (Issuer)

4 - Soliton, Inc. (0001548187) (Issuer)

4 - Soliton, Inc. (0001548187) (Issuer)

4 - Soliton, Inc. (0001548187) (Issuer)

4 - Soliton, Inc. (0001548187) (Issuer)

4 - Soliton, Inc. (0001548187) (Issuer)

4 - Soliton, Inc. (0001548187) (Issuer)

4 - Soliton, Inc. (0001548187) (Issuer)

4 - Soliton, Inc. (0001548187) (Issuer)

15-12B - Soliton, Inc. (0001548187) (Filer)

EFFECT - Soliton, Inc. (0001548187) (Filer)

EFFECT - Soliton, Inc. (0001548187) (Filer)

EFFECT - Soliton, Inc. (0001548187) (Filer)

S-8 POS - Soliton, Inc. (0001548187) (Filer)

S-8 POS - Soliton, Inc. (0001548187) (Filer)

S-8 POS - Soliton, Inc. (0001548187) (Filer)

POS AM - Soliton, Inc. (0001548187) (Filer)

POS AM - Soliton, Inc. (0001548187) (Filer)

POS AM - Soliton, Inc. (0001548187) (Filer)

SC 13D/A - Soliton, Inc. (0001548187) (Subject)